- Home
- RLAY vs SNX Comparison
RLAY vs SNX Comparison
Compare RLAY & SNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- SNX
- Stock Information
- Founded
- RLAY 2015
- SNX 1980
- Country
- RLAY United States
- SNX United States
- Employees
- RLAY N/A
- SNX N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- SNX Retail: Computer Software & Peripheral Equipment
- Sector
- RLAY Health Care
- SNX Technology
- Exchange
- RLAY Nasdaq
- SNX Nasdaq
- Market Cap
- RLAY 576.1M
- SNX 11.2B
- IPO Year
- RLAY 2020
- SNX 2003
- Fundamental
- Price
- RLAY $3.72
- SNX $141.31
- Analyst Decision
- RLAY Strong Buy
- SNX Strong Buy
- Analyst Count
- RLAY 11
- SNX 9
- Target Price
- RLAY $18.40
- SNX $140.89
- AVG Volume (30 Days)
- RLAY 1.5M
- SNX 1.1M
- Earning Date
- RLAY 08-05-2025
- SNX 06-24-2025
- Dividend Yield
- RLAY N/A
- SNX 1.25%
- EPS Growth
- RLAY N/A
- SNX 19.95
- EPS
- RLAY N/A
- SNX 8.55
- Revenue
- RLAY $7,679,000.00
- SNX $60,007,297,000.00
- Revenue This Year
- RLAY $14.31
- SNX $3.34
- Revenue Next Year
- RLAY N/A
- SNX $4.55
- P/E Ratio
- RLAY N/A
- SNX $16.48
- Revenue Growth
- RLAY N/A
- SNX 6.60
- 52 Week Low
- RLAY $1.78
- SNX $92.23
- 52 Week High
- RLAY $10.72
- SNX $145.10
- Technical
- Relative Strength Index (RSI)
- RLAY 64.56
- SNX 73.50
- Support Level
- RLAY $3.50
- SNX $138.25
- Resistance Level
- RLAY $3.75
- SNX $141.81
- Average True Range (ATR)
- RLAY 0.22
- SNX 3.52
- MACD
- RLAY 0.03
- SNX 0.64
- Stochastic Oscillator
- RLAY 94.87
- SNX 96.31
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.